Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Gallo

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Plos One|September 7, 2013
Forming a complex with MHC class I molecules interferes with mouse CD1d functional expressionRenukaradhya J Gourapura, Masood A Khan, Richard M Gallo, et al.
European Journal of Immunology|November 24, 2018
JNK2 modulates the CD1d-dependent and -independent activation of iNKT cellsJianyun Liu, Richard M Gallo, Masood A Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Statins impair CD1d-mediated antigen presentation through the inhibition of prenylationMasood A Khan, Richard M Gallo, Gourapura J Renukaradhya, et al.
The Biochemical Journal|January 6, 2012
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonistKristy J Wilson, Christopher P Mill, Richard M Gallo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1dRichard M Gallo, Masood A Khan, Jianjian Shi, et al.
Cancer Letters|March 15, 2003
A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell linesEric E Williams, Laurie J Trout, Richard M Gallo, et al.
Growth Factors (Chur, Switzerland)|January 21, 2012
EGFR ligands exhibit functional differences in models of paracrine and autocrine signalingKristy J Wilson, Christopher Mill, Sydney Lambert, et al.
Oncogene|December 9, 2003
Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinaseStuart S Hobbs, Elizabeth M Cameron, Robert P Hammer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos One|September 7, 2013
Forming a complex with MHC class I molecules interferes with mouse CD1d functional expressionRenukaradhya J Gourapura, Masood A Khan, Richard M Gallo, et al.
European Journal of Immunology|November 24, 2018
JNK2 modulates the CD1d-dependent and -independent activation of iNKT cellsJianyun Liu, Richard M Gallo, Masood A Khan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Statins impair CD1d-mediated antigen presentation through the inhibition of prenylationMasood A Khan, Richard M Gallo, Gourapura J Renukaradhya, et al.
The Biochemical Journal|January 6, 2012
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonistKristy J Wilson, Christopher P Mill, Richard M Gallo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Regulation of the actin cytoskeleton by Rho kinase controls antigen presentation by CD1dRichard M Gallo, Masood A Khan, Jianjian Shi, et al.
Cancer Letters|March 15, 2003
A constitutively active ErbB4 mutant inhibits drug-resistant colony formation by the DU-145 and PC-3 human prostate tumor cell linesEric E Williams, Laurie J Trout, Richard M Gallo, et al.
Growth Factors (Chur, Switzerland)|January 21, 2012
EGFR ligands exhibit functional differences in models of paracrine and autocrine signalingKristy J Wilson, Christopher Mill, Sydney Lambert, et al.
Oncogene|December 9, 2003
Five carboxyl-terminal residues of neuregulin2 are critical for stimulation of signaling by the ErbB4 receptor tyrosine kinaseStuart S Hobbs, Elizabeth M Cameron, Robert P Hammer, et al.
Pageof 2